Navigation Links
Additional Data From Multiple Phase 1 and 2 Studies of S*BIO's Novel JAK2 Inhibitor SB1518 Demonstrate Safety and Efficacy for Treatment of Symptomatic Myelofibrosis (MF)
Date:6/1/2011

SINGAPORE, June 1, 2011 /PRNewswire/ -- S*BIO Pte Ltd today announced that additional data from multiple Phase 1 and 2 clinical studies of its novel JAK2 inhibitor SB1518 further confirmed safety and efficacy for the treatment of patients with symptomatic myelofibrosis (MF) and enlarged spleens. In the studies, SB1518 alleviated MF-associated splenomegaly and showed no evidence of myelosuppression and no exacerbation of cytopenias. Results will be presented at the American Society of Clinical Oncology (ASCO) 2011 Annual Meeting in Chicago and the 16th Congress of the European Hematology Association (EHA) in London.

"Data pooled from the two Phase 1 trials demonstrate sustained clinical benefit in MF patients when treated with SB1518," said John Seymour, Head of the Department of Haematology at the Peter MacCallum Cancer Centre, Melbourne, "The once-daily dosing was well tolerated for over 2 years in on-going patients with no long-term toxicities observed."

Ruben A. Mesa, M.D., principal investigator at Mayo Clinic, said, "The new data from the Phase 2 study clearly showed durable responses in both spleen volume reduction and in relieving MF related symptoms. More importantly, these treatment effects were observed in MF patients with significantly impaired hematopoiesis without further exacerbating cytopenias. These results show that treatment with SB1518 is particularly important for MF patients with impaired hematopoiesis. The side effects were generally low grade, easily manageable and there were no discontinuations due to GI toxicities."

Dr. Jan-Anders Karlsson, CEO of S*BIO, added, "The data are further evidence that SB1518 is safe, effective and well tolerated in MF patients including those who present with severe splenomegaly.  The convenient once daily dose was well tolerated with manageable side effects across all studies. In light of these positive and encouraging results, we are rapidly advancing our JAK2 inhibitor through lat
'/>"/>

SOURCE S*BIO Pte Ltd
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine technology :

1. Additional Data From QNEXA Clinical Trials Presented at the European Congress on Obesity
2. Hope Paige Designs Medical ID Bracelets Now Available in 1,100 Additional Locations
3. Ardea Biosciences Provides Additional Results From a Phase 2b Study of Lesinurad in Combination With Allopurinol at the Annual European Congress of Rheumatology
4. Omeros Reports Allowance of Additional Patent for Arthroscopic Product
5. Cynosure Receives Additional International Regulatory Approvals for New Cellulite Reduction Workstations
6. Data Presented at Digestive Disease Week Highlights Additional Analysis of DIFICID™ Phase 3 Data
7. Rosetta Genomics Announces Issuance of Additional U.S. Patent
8. HeartWare Reports Additional Data from Bridge-to-Transplant Clinical Trial and Continued Access Patients
9. Johnson & Johnson Provides Additional Information Regarding Amended Agreement With Merck
10. Southern Home Medical Equipment Reports Additional Revenues and Profits for 2010
11. Additional 8 Products of DK Sinopharma, Inc. are Included in 2010 Provincial Medical Insurance Catalogs in 4 Separate Provinces in the Peoples Republic of China
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/7/2015)... , July 7, 2015  PAREXEL International Corporation (NASDAQ: ... and Fiscal Year 2015 on Wednesday, August 5 th , ... will be available on PAREXEL,s website at www.PAREXEL.com ... PAREXEL will host a conference call and live webcast ... 2015 to discuss the results.  To access the webcast, visit ...
(Date:7/7/2015)... SHENZHEN, China , July 7, 2015 /PRNewswire/ -- ... ), a leading developer, manufacturer and marketer of ... to acquire the remaining stake in Wuhan Dragonbio ... million. Dragonbio is a domestic ... joint and other surgical products. Prior to today,s ...
(Date:7/7/2015)... , July 7, 2015 ... new generation of drugs within human and veterinary ... sales company in the United States ... Vet-CA1, its leading companion animal therapeutic. ... http://photos.prnewswire.com/prnh/20150703/228329 ) , Paccal ...
Breaking Medicine Technology:PAREXEL International Announces Date Of Fourth Quarter And Fiscal Year 2015 Earnings Release And Conference Call 2Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 2Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 3Mindray Medical to Acquire the Remaining Stake in Wuhan Dragonbio 4Oasmia Pharmaceutical Launches US Brand and Sales Platform 2
... Londe, M.D. Contributing Editor The outcome of many illnesses ... (ICUs) has not improved dramatically over the past decades, ... and pharmacological support of vital organ systems. Indeed, ... five days have a 20 percent risk of death ...
... level of blood oxygenation can be an essential ... in the clinical setting is often desirable. In ... technology into easily used point-of-care devices, recent products ... values., ,HemoCue, Inc., Lake Forest, Calif., says that ...
Cached Medicine Technology:Tight Glycemic Control in the ICU 2Tight Glycemic Control in the ICU 3Hemoglobin Testing at the Point of Care 2Hemoglobin Testing at the Point of Care 3
(Date:7/7/2015)... , ... July 07, 2015 , ... ... Ellen Purdy as the company’s new Chief Financial Officer, effective July 6th, 2015. ... experience in companies ranging from a multi-billion dollar, global chemical company to early ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... with strong managerial expertise to oversee large healthcare operations and their success ... business partners, insurance companies, and regulators. American Sentinel University, an innovative, accredited ...
(Date:7/7/2015)... ... July 07, 2015 , ... ... has announced the release of Service Pack 5600 for its Call Accounting ... of enhancements to the already robust capabilities of the reporting platform, including ...
(Date:7/7/2015)... ... July 07, 2015 , ... On May 29, 2015, Health Canada announced ... use of gluten-free claims for gluten free oats and foods that contain them as ... Certification Program (GFCP) to include gluten-free oat products in Canada,” says Frank Massong, ...
(Date:7/7/2015)... MEMPHIS, Tennessee (PRWEB) , ... July 07, 2015 , ... Connexion Point is holding an ... fair will be held at 1769 Paragon Place, Suite 100, this upcoming Wednesday, July 8, ... onsite job fair, Connexion Point will be recruiting new applicants as well as holding onsite ...
Breaking Medicine News(10 mins):Health News:Office Practicum Announces new CFO 2Health News:American Sentinel University Details Six Ways Healthcare Leaders Can Sharpen Communications Skills 2Health News:American Sentinel University Details Six Ways Healthcare Leaders Can Sharpen Communications Skills 3Health News:American Sentinel University Details Six Ways Healthcare Leaders Can Sharpen Communications Skills 4Health News:ISI Telemanagement Solutions, Inc. Releases Service Pack 5600 for Infortel® Select 2Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 2Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 3Health News:Holy Crap Plus Gluten Free Oats Is The First Product With Oats In Canada To Carry The Gluten-Free Certification Program Trademark 4Health News:Connexion Point, a tech enabled healthcare services company, is holding on-site job fair July 8th and 9th to fill 400 positions at its new Memphis location 2
... By Alan Mozes HealthDay Reporter , ... every four U.S. health-care workers use some form of ... healthy, a new report shows. What,s more, doctors, ... were actually more likely than the general ...
... By Steven Reinberg HealthDay Reporter , THURSDAY, ... Steve Jobs, tenure as CEO of Apple Inc. was the ... from the iPod to the iPhone to the iPad -- ... he was stepping down as the head of the hugely ...
... By Jenifer Goodwin HealthDay Reporter , THURSDAY, Aug. ... most dreaded afflictions of old age, but the announcement by ... at age 59 has put a spotlight on the less ... , , About 500,000 people in the United States, or ...
... Steven Reinberg HealthDay Reporter , THURSDAY, Aug. ... face higher odds of dying if they,re admitted over ... study finds equally good results for patients treated at ... the so-called "weekend effect" -- an increased risk of ...
... clinic isn,t enough to keep some trauma patients who have ... department (ED) for follow-up care, even for such minor needs ... Johns Hopkins research. Reporting in the Annals of ... Medicare and those with no insurance were 60 percent more ...
... , THURSDAY, Aug. 25 (HealthDay News) -- In ... a tornado, earthquake or fire, most dialysis patients don,t have ... to a new study. Although these kidney-disease patients rely ... University of North Carolina School of Medicine found that many ...
Cached Medicine News:Health News:Many Health-Care Workers Have Turned to Alternative Medicine 2Health News:Many Health-Care Workers Have Turned to Alternative Medicine 3Health News:Steve Jobs Faces Uphill Battle Against Cancer: Experts 2Health News:Steve Jobs Faces Uphill Battle Against Cancer: Experts 3Health News:Coach Summitt's Diagnosis Puts Spotlight on Early-Onset Alzheimer's 2Health News:Coach Summitt's Diagnosis Puts Spotlight on Early-Onset Alzheimer's 3Health News:Coach Summitt's Diagnosis Puts Spotlight on Early-Onset Alzheimer's 4Health News:Specialized Stroke Centers Deliver on the Weekends 2Health News:Specialized Stroke Centers Deliver on the Weekends 3Health News:Uninsured trauma patients are more likely to use the ED for follow-up care 2Health News:Uninsured trauma patients are more likely to use the ED for follow-up care 3Health News:Dialysis Patients Unprepared for Disasters, Study Contends 2
Replacement bulb for Vibratome light system....
These specialty razor blades are feather thin and very sharp. Most users have found an increased quality level in Vibratome sections with these blades....
The care package includes a spare motor, fuse, Spare Fluorescent Bulb, additional Vibratome Feather Blades, Specimen Adhesive, Specimen Mounting Blocks, and a Specimen Tray....
... The Specimen Tray accessory fits inside the existing ... working area for tissue sectioning. Specimens are ... tray. This is a great option if ... expensive buffer, or wish to utilize the black ...
Medicine Products: